Govt issues administration guidelines for usage of CanSIno COVID-19 vaccine

The National Command and Operation Centre (NCOC) issued guidelines on Tuesday regarding safe usage of the Chinese single-dose CanSin. 

As per guidelines, the CanSino vaccine will be administered to people over 18 years of age. Citizens under 18 years of age won’t be administered the single-dose CanSino COVID-19 vaccine

The NCOC has recommended that people suffering from fever and currently Covid positive should not be administered the AstraZeneca vaccine.

• Who should not receive Vaccine
• Individuals having fever at the time of coming for vaccination (Can be rescheduled after the illness is settled)
• Patients with active COVID-19
• Those with mild COVID-19 can receive the vaccine once the isolation period is complete.
• Those with severe COVID-19 can receive the vaccine once they become stable
• Individuals on short-term immunosuppressive medication should wait for 28 day after themedication ends.
• Those chronically immunosuppressed may receive the vaccine, though efficacy may be lower
• That post-transplantation may receive the vaccine 3 months after transplantation
• That post-chemotherapy may receive the vaccine 28 days after chemotherapy
• Those having severe and/or uncontrolled cardiovascular disease, respiratory disease, gastrointestinal disease, liver disease, renal disease, endocrine disorder and neurological illness.
  

  Vaccine Storage

  Storage and transportation in refrigerated (2-8oC) condition

• Do not freeze the vaccine in any circumstance
• Protect the vaccine from direct exposure to sunlight

  Vaccine Administration

• Route of Administration: Intramuscular
• Site of Administration: Lateral Deltoid Muscle (Upper Arm), Non-dominant side
• Dose: 0.5ml/vial
• Presentation: Single-dose
• Regimen: Single shot

  Federal Minister for Planning, Development, Reforms and Special Initiatives Asad Umar had said last week that Pakistan will receive 4 million doses of China’s CanSino vaccine by the end of April.